The Global Drug Delivery Devices Market is segmented based on product type, end-user, distribution channel, and geography.
Global Drug Delivery Devices Market has accounted for USD 950.0 billion in 2015 and is expected to reach USD 1,625.1 billion by 2022, growing at a CAGR of 8.0% in the forecasted period 2016 to 2022.
Request Sample Report: Global Drug Delivery Devices Marke… Forecast to 2022
Based on product type the drug delivery devices market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug.
- Advertising -
On the basis of distribution channel the market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy.
Based on end-users the drug delivery devices market are further segmented into hospitals, over the counter, clinics, home healthcare, community healthcare, and others.
Based on geographical segmentation the drug delivery devices market is segmented into regions such as North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries such as U.S.
Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa. The report includes market shares of drug delivery devices market for North America, Europe and Asia Pacific.
Read more about the report: Global Drug Delivery Devices Marke…at 8.0% till 2022
Global Player Operating in the Global Drug Delivery Devices Market:
- Bayer AG
- Johnson & Johnson
- Novartis AG, Pfizer, Inc.
- GlaxoSmithKline plc.
- Merck & Co.
- Sanofi, Antares Pharma
- Becton Dickinson and Company
- Cima Labs, Inc.
- Dali Medical Devices
- Skyepharma AG
- Valeant Pharmaceuticals DSM Biomedical
- Catalent, Inc.
Browse Full Report: Global Drug Delivery Devices Marke… Forecast to 2022
For more information: